Treatment with DNH-III-14 decreased c-Kit expression by almost three-fold; therefore, we decided to further explore the effect of the compounds on c-Kit expression in neuroendocrine cancer cell lines. This evidence concerns the gene KIT and neuroendocrine carcinoma.